Table of Contents 1 Market Overview 1.1 Peptide Therapeutics Introduction 1.2 Market Analysis by Type 1.2.1 Injection 1.2.2 Oral 1.2.3 Other 1.3 Market Analysis by Applications 1.3.1 Cancer 1.3.2 Metabolic Disorders 1.3.3 Central Nervous System 1.3.4 Other 1.4 Market Analysis by Countries 1.4.1 China Status and Prospect (2013-2023) 1.4.2 Korea Status and Prospect (2013-2023) 1.4.3 Japan Status and Prospect (2013-2023) 1.4.4 Taiwan Status and Prospect (2013-2023) 1.4.5 Southeast Asia Status and Prospect (2013-2023) 1.4.6 India Status and Prospect (2013-2023) 1.4.7 Australia Status and Prospect (2013-2023) 1.5 Market Dynamics 1.5.1 Market Opportunities 1.5.2 Market Risk 1.5.3 Market Driving Force 2 Manufacturers Profiles 2.1 Sanofi 2.1.1 Business Overview 2.1.2 Peptide Therapeutics Type and Applications 2.1.2.1 Type 1 2.1.2.2 Type 2 2.1.3 Sanofi Peptide Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.2 Teva 2.2.1 Business Overview 2.2.2 Peptide Therapeutics Type and Applications 2.2.2.1 Type 1 2.2.2.2 Type 2 2.2.3 Teva Peptide Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.3 Novo Nordisk 2.3.1 Business Overview 2.3.2 Peptide Therapeutics Type and Applications 2.3.2.1 Type 1 2.3.2.2 Type 2 2.3.3 Novo Nordisk Peptide Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.4 Takeda 2.4.1 Business Overview 2.4.2 Peptide Therapeutics Type and Applications 2.4.2.1 Type 1 2.4.2.2 Type 2 2.4.3 Takeda Peptide Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.5 Eli Lilly 2.5.1 Business Overview 2.5.2 Peptide Therapeutics Type and Applications 2.5.2.1 Type 1 2.5.2.2 Type 2 2.5.3 Eli Lilly Peptide Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.6 AstraZeneca 2.6.1 Business Overview 2.6.2 Peptide Therapeutics Type and Applications 2.6.2.1 Type 1 2.6.2.2 Type 2 2.6.3 AstraZeneca Peptide Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.7 Novartis 2.7.1 Business Overview 2.7.2 Peptide Therapeutics Type and Applications 2.7.2.1 Type 1 2.7.2.2 Type 2 2.7.3 Novartis Peptide Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.8 Shire 2.8.1 Business Overview 2.8.2 Peptide Therapeutics Type and Applications 2.8.2.1 Type 1 2.8.2.2 Type 2 2.8.3 Shire Peptide Therapeutics Sales, Price, Revenue, Gross Margi

List of Tables and Figures Figure Peptide Therapeutics Picture Table Product Specifications of Peptide Therapeutics Figure Asia-Pacific Sales Market Share of Peptide Therapeutics by Types in 2017 Table Types of Peptide Therapeutics Figure Injection Picture Figure Oral Picture Figure Other Picture Figure Asia-Pacific Peptide Therapeutics Sales Market Share by Applications in 2017 Table Applications of Peptide Therapeutics Figure Cancer Picture Figure Metabolic Disorders Picture Figure Central Nervous System Picture Figure Other Picture Figure China Peptide Therapeutics Revenue (Million USD) and Growth Rate (2013-2023) Figure Korea Peptide Therapeutics Revenue (Million USD) and Growth Rate (2013-2023) Figure Japan Peptide Therapeutics Revenue (Million USD) and Growth Rate (2013-2023) Figure Taiwan Peptide Therapeutics Revenue (Million USD) and Growth Rate (2013-2023) Figure Southeast Asia Peptide Therapeutics Revenue (Million USD) and Growth Rate (2013-2023) Figure India Peptide Therapeutics Revenue (Million USD) and Growth Rate (2013-2023) Figure Australia Peptide Therapeutics Revenue (Million USD) and Growth Rate (2013-2023) Table Sanofi Basic Information, Manufacturing Base and Competitors Table Sanofi Peptide Therapeutics Type and Applications Table Sanofi Peptide Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Teva Basic Information, Manufacturing Base and Competitors Table Teva Peptide Therapeutics Type and Applications Table Teva Peptide Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Novo Nordisk Basic Information, Manufacturing Base and Competitors Table Novo Nordisk Peptide Therapeutics Type and Applications Table Novo Nordisk Peptide Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Takeda Basic Information, Manufacturing Base and Competitors Table Takeda Peptide Therapeutics Type and Applications Table Takeda Peptide Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Eli Lilly Basic Information, Manufacturing Base and Competitors Table Eli Lilly Peptide Therapeutics Type and Applications Table Eli Lilly Peptide Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table AstraZeneca Basic Information, Manufacturing Base and Competitors Table AstraZeneca Peptide Therapeutics Type and Applications Table AstraZeneca Peptide Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Novartis Basic Information, Manufacturing Base and Competitors Table Novartis Peptide Therapeutics Type and Applications Table Novartis Peptide Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Shire Basic Information, Manufacturing Base and Competitors Table Shire Peptide Therapeutics Type and Applications Table Shire Peptide Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table AbbVie Basic Information, Manufactur